MUGENBIO
Description: Medtech startup developing next-gen diagnostic platform for early, accurate prostate cancer detection.
Country: Switzerland
Based in: Zurich
Founded: 2022
Funding Stage: Pre-Seed
Tags: ['The Next-Generation Cancer Diagnostic']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
